China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026)
China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | 37.35 Bn |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 4.00 Bn |
| 3 | Zoetis | 32.51 Bn | 30.56 Bn | 1.62 Bn | 3.72 Bn |
| 4 | Takeda Pharmaceutical | 27.58 Bn | 23.52 Bn | 4.39 Bn | 13.52 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.02 Bn | 648.10 Mn | 1.84 Bn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | 49,000.00 |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 2.53 Bn |
| 8 | Neurocrine Biosciences | 17.94 Bn | 16.63 Bn | 800.70 Mn | 90.90 Mn |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 1.40 Bn |
| 10 | China SXT Pharmaceuticals | 48,119.08 | -28.13 Mn | - | 117,103.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,103.00 |
| Mar 31, 2026 | 117,103.00 |
| Sep 30, 2025 | 153,079.00 |
| Sep 30, 2025 | 153,079.00 |
| Mar 31, 2025 | 178,561.00 |
| Mar 31, 2025 | 178,561.00 |
| Sep 30, 2024 | 230,142.00 |
| Sep 30, 2024 | 230,142.00 |
| Mar 31, 2024 | 328,845.00 |
| Mar 31, 2024 | 328,845.00 |
| Sep 30, 2023 | 809,039.00 |
| Sep 30, 2023 | 809,039.00 |
| Mar 31, 2023 | 962,214.00 |
| Mar 31, 2023 | 962,214.00 |
| Sep 30, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.30 Mn |